121 related articles for article (PubMed ID: 1632076)
1. Use of rats to compare atrophic rhinitis vaccines for protection against effects of heat-labile protein toxin produced by Pasteurella multocida serogroup D.
Thurston JR; Rimler RB; Ackermann MR; Cheville NF
Vet Immunol Immunopathol; 1992 Jun; 33(1-2):155-62. PubMed ID: 1632076
[TBL] [Abstract][Full Text] [Related]
2. Protection of Pasteurella multocida dermonecrotic toxin-challenged rats by toxoid-induced antibody.
Pettit RK; Rimler RB; Ackermann MR
Vet Microbiol; 1993 Feb; 34(2):167-73. PubMed ID: 8451832
[TBL] [Abstract][Full Text] [Related]
3. Immunity induced in rats vaccinated with toxoid prepared from heat-labile toxin produced by Pasteurella multocida serogroup D.
Thurston JR; Rimler RB; Ackermann MR; Cheville NF; Sacks JM
Vet Microbiol; 1991 Apr; 27(2):169-74. PubMed ID: 2063548
[TBL] [Abstract][Full Text] [Related]
4. Immune responses of piglets to Pasteurella multocida toxin and toxoid.
van Diemen PM; de Vries Reilingh G; Parmentier HK
Vet Immunol Immunopathol; 1994 Jun; 41(3-4):307-21. PubMed ID: 7941310
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.
Liao CM; Huang C; Hsuan SL; Chen ZW; Lee WC; Liu CI; Winton JR; Chien MS
Vaccine; 2006 Jan; 24(1):27-35. PubMed ID: 16122849
[TBL] [Abstract][Full Text] [Related]
6. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
Sakano T; Okada M; Taneda A; Mukai T; Sato S
J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
[TBL] [Abstract][Full Text] [Related]
7. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs.
To H; Someno S; Nagai S
Am J Vet Res; 2005 Jan; 66(1):113-8. PubMed ID: 15691045
[TBL] [Abstract][Full Text] [Related]
8. [Detection of neutralizing antibodies against Pasteurella multocida toxin in swine with atrophic rhinitis].
Bechmann G; Schöss P
Dtsch Tierarztl Wochenschr; 1991 Aug; 98(8):310-2. PubMed ID: 1935682
[TBL] [Abstract][Full Text] [Related]
9. Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.
Petersen SK; Foged NT; Bording A; Nielsen JP; Riemann HK; Frandsen PL
Infect Immun; 1991 Apr; 59(4):1387-93. PubMed ID: 1706320
[TBL] [Abstract][Full Text] [Related]
10. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
Seo J; Pyo H; Lee S; Lee J; Kim T
Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
[TBL] [Abstract][Full Text] [Related]
11. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
Suckow MA
Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
[TBL] [Abstract][Full Text] [Related]
12. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
[TBL] [Abstract][Full Text] [Related]
13. Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs.
Foged NT
APMIS Suppl; 1992; 25():1-56. PubMed ID: 1576005
[No Abstract] [Full Text] [Related]
14. Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs.
Bording A; Nymark K; Smidt E
Acta Vet Scand; 1994; 35(2):155-63. PubMed ID: 7942381
[TBL] [Abstract][Full Text] [Related]
15. [Atrophic rhinitis of swine: neutralization of the toxin of Pasteurella multocida].
Schimmelpfennig H
Dtsch Tierarztl Wochenschr; 1990 May; 97(5):195-6. PubMed ID: 2364889
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine.
Hsuan SL; Liao CM; Huang C; Winton JR; Chen ZW; Lee WC; Liao JW; Chen TH; Chiou CJ; Yeh KS; Chien MS
Vaccine; 2009 May; 27(22):2923-9. PubMed ID: 19428902
[TBL] [Abstract][Full Text] [Related]
17. Protection by toxoid-induced antibody of gnotobiotic piglets challenged with the dermonecrotic toxin of Pasteurella multocida.
Frymus T; Müller E; Franz B; Petzoldt K
Zentralbl Veterinarmed B; 1989 Nov; 36(9):674-80. PubMed ID: 2532834
[TBL] [Abstract][Full Text] [Related]
18. Serological potency testing of vaccines against progressive atrophic rhinitis.
Oppling V; Kusch M; Rübmann P; Cussler K
Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
[No Abstract] [Full Text] [Related]
19. Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.
Hur J; Byeon H; Lee JH
Can J Vet Res; 2014 Oct; 78(4):297-303. PubMed ID: 25355999
[TBL] [Abstract][Full Text] [Related]
20. Atypical Pasteurella strains producing a toxin similar to the dermonecrotic toxin of Pasteurella multocida subspecies multocida.
Kamp EM; ter Laak EA; de Jong MF
Vet Rec; 1990 Apr; 126(17):434-7. PubMed ID: 2111955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
